# Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI)

Study · id `cardio:ct-nct03145675` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03145675](<https://clinicaltrials.gov/study/NCT03145675>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03145675

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 378 participants.

## Technical summary

Registry record NCT03145675. Randomized; no masking; primary purpose treatment. Start 2017-05-12 (actual); primary completion 2022-04-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 378 participants (enrolled count; ClinicalTrials.gov record NCT03145675, source copy `cardio:ctgov-nct03145675-2022-10-12`, retrieved 2026-10-26)
- Started: 2017-05-12 (actual) (ClinicalTrials.gov record NCT03145675, source copy `cardio:ctgov-nct03145675-2022-10-12`, retrieved 2026-10-26)
- Primary completion: 2022-04-20 (actual) (ClinicalTrials.gov record NCT03145675, source copy `cardio:ctgov-nct03145675-2022-10-12`, retrieved 2026-10-26)
- Completion: 2022-07-14 (actual) (ClinicalTrials.gov record NCT03145675, source copy `cardio:ctgov-nct03145675-2022-10-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03145675, source copy `cardio:ctgov-nct03145675-2022-10-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03145675-2022-10-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI)
- Acronym: OPTIENOX-PCI
- Condition: Coronary Artery Disease
- Condition: Percutaneous Coronary Intervention
- Intervention (Drug): Enoxaparin (Staged-dose PCI Group)
- Intervention (Drug): Enoxaparin (Single-dose PCI Group)
- Intervention (Drug): Enoxaparin (High-dose Group)
- Intervention (Drug): Enoxaparin (Standard-dose Group)
- Lead sponsor: Peking Union Medical College Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Enoxaparin (`core:enoxaparin`)
- Registry lists this organization as the lead sponsor: Peking Union Medical College Hospital (`cardio:org-peking-union-medical-college-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Trough anticoagulant levels of high-dose versus standard-dose intravenous enoxaparin in patients undergoing trans-radial coronary angiography alone (`cardio:pubmed-41714948`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5d17257010114f1f62174914ebc9ecdb8db467865af7723a5d61e24ceff3b26b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
